
Home>>Is inhibition of phosphodiesterase type 5 by sildenafil a promising therapy for volume-overload heart failure?
Publication:
abstract
Related Articles
Long-term effects of sildenafil in a rat model of chronic mitral regurgitation: benefits of ventricular remodeling and exercise capacity.
Circulation. 2012
Long-term effects of sildenafil in a rat model of chronic mitral regurgitation: benefits of ventricular remodeling and exercise capacity.
Kim KH, Kim YJ, Ohn JH, Yang J, Lee SE, Lee SW, Kim HK, Seo JW, Sohn DW. Circulation. 2012 Mar 20; 125(11):1390-401. Epub 2012 Feb 8.
Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Hypertension. 2012
Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Xie YP, Chen B, Sanders P, Guo A, Li Y, Zimmerman K, Wang LC, Weiss RM, Grumbach IM, Anderson ME, et al. Hypertension. 2012 Feb; 59(2):355-62. Epub 2011 Dec 27.
Res-erection of Viagra as a heart drug.
Circ Heart Fail. 2011
Res-erection of Viagra as a heart drug.
Kass DA. Circ Heart Fail. 2011 Jan; 4(1):2-4.
Review Sildenafil and phosphodiesterase-5 inhibitors for heart failure.
Curr Heart Fail Rep. 2008
Review Sildenafil and phosphodiesterase-5 inhibitors for heart failure.
Guazzi M. Curr Heart Fail Rep. 2008 Jun; 5(2):110-4.
Review Controversies in ventricular remodelling.
Lancet. 2006
Review Controversies in ventricular remodelling.
Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Lancet. 2006 Jan 28; 367(9507):356-67.
